Cat.#: ACPP-1278
| Despition | EAAT1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1760 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1760) | 100 µg | inquiry |
| ACPP-1351 | Dopamine D2 Receptor Blocking Peptide (AC1351) | 250 µg | inquiry |
| ACPP-1027 | Recombinant Human Ephrin A3 Protein (Fc Tag) (AC1027) | 50 µg | inquiry |
| ACPP-1281 | ULK1 Blocking Peptide (AC1281) | 250 µg | inquiry |
| ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg | inquiry |
| ACPP-1814 | PPA E.Coli (AC1814) | 5 µg | inquiry |
| ACPP-1200 | PAX8 Blocking Peptide (AC1200) | 250 µg | inquiry |
| ACPP-1466 | Human ATG10 Protein (AC1466) | 5 µg | inquiry |
| ACPP-1096 | Synthetic Nanodisc Human CXCR4 Protein (AC1096) | 10 µg | inquiry |
| ACPP-1687 | Mouse Visfatin Protein (AC1687) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.